Andreas Pahl
Chief Executive Officer at HEIDELBERG PHARMA AG
Andreas Pahl active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HEIDELBERG PHARMA AG | Chief Executive Officer | 31/01/2024 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2011 | 31/01/2024 | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Chief Executive Officer | 31/01/2024 | - |
| Chief Tech/Sci/R&D Officer | 31/08/2012 | 31/01/2024 |
Career history of Andreas Pahl
Former positions of Andreas Pahl
| Companies | Position | Start | End |
|---|---|---|---|
| Nycomed GmbH | Corporate Officer/Principal | - | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Director/Board Member | - | - |
| Friedrich-Alexander University of Erlangen-Nuremberg | Corporate Officer/Principal | - | - |
| Technical University of Berlin | Corporate Officer/Principal | - | - |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Chief Tech/Sci/R&D Officer | 31/08/2012 | - |
Training of Andreas Pahl
| Humboldt-Universität zu Berlin | Undergraduate Degree |
Statistics
International
| Germany | 9 |
| Japan | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 4 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| HEIDELBERG PHARMA AG | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Heidelberg Pharma AG /Old/
Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Health Technology |
| Nycomed GmbH |
- Stock Market
- Insiders
- Andreas Pahl
- Experience
